204 related articles for article (PubMed ID: 22404638)
1. Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.
Koo S; Baden LR; Marty FM
Clin Microbiol Infect; 2012 May; 18(5):E122-7. PubMed ID: 22404638
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of the (1-3)-β-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers.
Son HJ; Sung H; Park SY; Kim T; Lee HJ; Kim SM; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
PLoS One; 2017; 12(11):e0188860. PubMed ID: 29190812
[TBL] [Abstract][Full Text] [Related]
3. Disseminated aspergillosis following resolution of Pneumocystis pneumonia with sustained elevation of beta-glucan in an Intensive Care Unit: a case report.
Saito T; Shime N; Itoh K; Fujita N; Saito Y; Shinozaki M; Shibuya K; Makimura K; Hashimoto S
Infection; 2009 Dec; 37(6):547-50. PubMed ID: 19730788
[TBL] [Abstract][Full Text] [Related]
4. Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases.
De Carolis E; Marchionni F; Torelli R; Angela MG; Pagano L; Murri R; De Pascale G; De Angelis G; Sanguinetti M; Posteraro B
PLoS One; 2020; 15(7):e0236095. PubMed ID: 32726358
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
White PL; Price JS; Posso RB; Barnes RA
Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
[TBL] [Abstract][Full Text] [Related]
6. Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.
Damiani C; Le Gal S; Da Costa C; Virmaux M; Nevez G; Totet A
J Clin Microbiol; 2013 Oct; 51(10):3380-8. PubMed ID: 23903553
[TBL] [Abstract][Full Text] [Related]
7. Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy.
Desmet S; Van Wijngaerden E; Maertens J; Verhaegen J; Verbeken E; De Munter P; Meersseman W; Van Meensel B; Van Eldere J; Lagrou K
J Clin Microbiol; 2009 Dec; 47(12):3871-4. PubMed ID: 19846641
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.
Onishi A; Sugiyama D; Kogata Y; Saegusa J; Sugimoto T; Kawano S; Morinobu A; Nishimura K; Kumagai S
J Clin Microbiol; 2012 Jan; 50(1):7-15. PubMed ID: 22075593
[TBL] [Abstract][Full Text] [Related]
9. Comparative Analysis of the Wako β-Glucan Test and the Fungitell Assay for Diagnosis of Candidemia and Pneumocystis jirovecii Pneumonia.
Friedrich R; Rappold E; Bogdan C; Held J
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29899003
[TBL] [Abstract][Full Text] [Related]
10. (1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis.
Jaijakul S; Vazquez JA; Swanson RN; Ostrosky-Zeichner L
Clin Infect Dis; 2012 Aug; 55(4):521-6. PubMed ID: 22573851
[TBL] [Abstract][Full Text] [Related]
11. Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit.
Lo Cascio G; Koncan R; Stringari G; Russo A; Azzini A; Ugolini A; Ligozzi M; Polati E; Cornaglia G; Concia E; Schweiger V
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):357-65. PubMed ID: 25217227
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
[TBL] [Abstract][Full Text] [Related]
13. Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.
Sax PE; Komarow L; Finkelman MA; Grant PM; Andersen J; Scully E; Powderly WG; Zolopa AR;
Clin Infect Dis; 2011 Jul; 53(2):197-202. PubMed ID: 21690628
[TBL] [Abstract][Full Text] [Related]
14. Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-β-D-glucan in HIV-infected patients: a retrospective case control study.
Hammarström H; Grankvist A; Broman I; Kondori N; Wennerås C; Gisslen M; Friman V
BMC Infect Dis; 2019 Jul; 19(1):658. PubMed ID: 31337356
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of the 1,3-β-D-glucan test for pneumocystis pneumonia in a tertiary university hospital in Denmark: A retrospective study.
Engsbro AL; Najat S; Jørgensen KM; Kurtzhals JAL; Arendrup MC
Med Mycol; 2019 Aug; 57(6):710-717. PubMed ID: 30535059
[TBL] [Abstract][Full Text] [Related]
16. β-d-Glucan kinetics for the assessment of treatment response in Pneumocystis jirovecii pneumonia.
Held J; Wagner D
Clin Microbiol Infect; 2011 Jul; 17(7):1118-22. PubMed ID: 21446990
[TBL] [Abstract][Full Text] [Related]
17. (1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients.
Esteves F; Lee CH; de Sousa B; Badura R; Seringa M; Fernandes C; Gaspar JF; Antunes F; Matos O
Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1173-80. PubMed ID: 24487911
[TBL] [Abstract][Full Text] [Related]
18. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
Pazos C; Pontón J; Del Palacio A
J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
[TBL] [Abstract][Full Text] [Related]
19. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
Bloos F; Held J; Schlattmann P; Brillinger N; Kurzai O; Cornely OA; Thomas-Rüddel D
Trials; 2018 Sep; 19(1):472. PubMed ID: 30180873
[TBL] [Abstract][Full Text] [Related]
20. Serum (1 → 3) β-D-glucan assay for discrimination between Pneumocystis jirovecii pneumonia and colonization.
Tasaka S; Kobayashi S; Yagi K; Asami T; Namkoong H; Yamasawa W; Ishii M; Hasegawa N; Betsuyaku T
J Infect Chemother; 2014 Nov; 20(11):678-81. PubMed ID: 25066434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
